Work

Optimising CAR T cell manufacturing for solid cancers

Year: 2019
Type: dissertation
Abstract: A new kind of cancer therapy uses a patient’s own T cells to carry a chimeric antigen receptor (CAR) that targets cancer cells as a key fits a lock. Once targeted, the CAR-T cells kill cancer cells. Although CAR-T cell therapy is a standard treatment for some blood cancers, it has been less successful in solid cancer patients. Therefore, in this study, I investigated the ability of T cells obtained from solid cancer patients, who were receiving chemotherapy, to result in the manufacture of CAR-T cell products that might be satisfactory for clinical use. The findings support the feasibility of successfully generating functional CAR-T cells from the peripheral blood of solid cancer patients even allowing for exposure to chemotherapy at advanced stages of disease. The results would encourage the use of this method for making CAR-T cell products from these patients in future clinical trials.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7216661996
Cites: 173
Cited by:
Related to: 10